secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dogwood Therapeutics, Inc. (DWTX)
CIK:        0001818844
Form:       8-K
Filed at:   2023-07-14T23:59:59+00:00
Accession:  0001558370-23-011892
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Virios Therapeutics enters $6.7M at-the-market equity offering with JonesTrading
--------------------------------------------------------------------------------

- Agreement allows sale of up to $6.7M of common stock via ATM offering under Rule 415.
- Agent JonesTrading receives 3% commission on gross sales; no obligation to sell shares.
- Offered under existing shelf registration statement S-3 (No. 333-263700), effective since April 2022.
- Agreement effective July 14, 2023; may be terminated by either party at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818844/000155837023011892/0001558370-23-011892-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818844/000155837023011892/tmb-20230714x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-011892

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer